Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Rodriguez

Showing results (171-180 of 231) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|February 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 22, 2020
Vascular Occlusion Evolution in Endovascular Reperfusion Candidates Transferred from Primary to Comprehensive Stroke CentersAlan Flores, Xavier Ustrell, Laia Seró, et al.
The Pediatric Infectious Disease Journal|November 17, 2025
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody TransferLeire Perez-Latorre, Shira H Cohen, Pablo J Sánchez, et al.
Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.
Journal of the American College of Cardiology|January 8, 2026
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresPhilip P Goodney, Elsie G Ross, Jeffrey T Bruckel, et al.
Circulation. Population Health and Outcomes|February 16, 2026
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresPhilip P Goodney, Elsie G Ross, Jeffrey T Bruckel, et al.
Blood Cancer Journal|December 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignanciesLuis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2020
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple MyelomaPaul G Richardson, Albert Oriol, Alessandra Larocca, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel OcclusionAlan Flores, Marcos Elizalde, Laia Seró, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Pageof 24

Showing results (171-180 of 231) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|February 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 22, 2020
Vascular Occlusion Evolution in Endovascular Reperfusion Candidates Transferred from Primary to Comprehensive Stroke CentersAlan Flores, Xavier Ustrell, Laia Seró, et al.
The Pediatric Infectious Disease Journal|November 17, 2025
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody TransferLeire Perez-Latorre, Shira H Cohen, Pablo J Sánchez, et al.
Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.
Journal of the American College of Cardiology|January 8, 2026
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresPhilip P Goodney, Elsie G Ross, Jeffrey T Bruckel, et al.
Circulation. Population Health and Outcomes|February 16, 2026
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresPhilip P Goodney, Elsie G Ross, Jeffrey T Bruckel, et al.
Blood Cancer Journal|December 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignanciesLuis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2020
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple MyelomaPaul G Richardson, Albert Oriol, Alessandra Larocca, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel OcclusionAlan Flores, Marcos Elizalde, Laia Seró, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Pageof 24